Friday, June 02, 2023 12:54:49 AM
HyGro,
Thanks for the reply. The ASCO presentation this Saturday will be awesome! There will be information presented about some of the topics that you have mentioned.
https://conferences.asco.org/am/industry-expert-theater
Title: Personalized Immune Therapies for Solid Tumors
Description: Immune cell therapies could become the next generation of interventions for solid tumors. Northwest Biotherapeutics is developing cell therapies for solid tumors. The presentation focuses on action mechanisms, immune responses, combination therapies, imaging analyses & manufacturing considerations.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171909324
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172029305
Thanks for the reply. The ASCO presentation this Saturday will be awesome! There will be information presented about some of the topics that you have mentioned.
https://conferences.asco.org/am/industry-expert-theater
Title: Personalized Immune Therapies for Solid Tumors
Description: Immune cell therapies could become the next generation of interventions for solid tumors. Northwest Biotherapeutics is developing cell therapies for solid tumors. The presentation focuses on action mechanisms, immune responses, combination therapies, imaging analyses & manufacturing considerations.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171909324
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172029305
Bullish
Believe carefully. This is the greatest and most powerful lesson that I have learned since arriving on Earth. Examine what you believe about yourself most importantly, and then believe carefully as you interact with the world.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
